抗老化薬の世界市場レポート 2024年

抗老化薬市場規模は近年力強く成長しています。2023年の537億6,000万米ドルから2024年には578億5,000万米ドルへと、CAGR7.6％で拡大します。過去数年間に見られた成長は、加齢に伴う慢性疾患の増加、加齢に関連した健康問題に対する意識の高まり、加齢研究に対する規制当局の支援、ウェルネスと長寿を重視する消費者など、いくつかの要因によるものです。これらの要因が総合的に、この時期の抗老化薬の開発と普及に貢献しました。

抗老化薬市場の成長は、高齢化人口の増加によって促進されると予測されます。この人口動態の変化は、社会における他の年齢層と比較して、60歳以上の高齢者の割合が増加していることを浮き彫りにしています。このシフトは、医療の進歩による寿命の延長、出生率の低下、社会・経済構造の変革の結果です。抗老化薬は、若々しい特徴を持つ個人の健康寿命を延ばすことを目的としています。例えば、2022年10月の世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上になると予測されており、2020年までに10億人だった高齢者は14億人に増加します。また、Eurostatのデータベースによると、65歳以上の高齢者は人口の21.1％を占め、前年から0.3％、10年前から3.1％増加しました。したがって、高齢化人口の急増が抗老化薬市場の成長を大きく後押ししています。

2023年の抗老化薬市場で最大の地域は北米でした。抗老化薬市場レポートに掲載されている地域は、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の抗老化薬市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の抗老化薬市場規模実績と成長、2018～2023年
• 世界の抗老化薬市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の抗老化薬市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• セラム
• クリーム
• ジェル
• その他
• 世界の抗老化薬市場、薬剤クラス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ホルモン療法
• 酸化防止剤
• 酵素
• 幹細胞
• 世界の抗老化薬市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 注射
• 経口
• 局所
• 世界の抗老化薬市場、成分別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• レチノイド
• ヒアルロン酸
• アルファヒドロキシ酸
• その他
• 世界の抗老化薬市場、医薬品用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 肌と髪
• 骨格と筋肉
• 加齢に関連した障害
• その他

第7章 地域と国の分析

• 世界の抗老化薬市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の抗老化薬市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗老化薬市場の競合情勢
• 抗老化薬市場の企業プロファイル
  • L'Oreal SA
  • Galderma SA
  • Merz Pharma GmbH &Co. KGaA
  • Sanofi SA
  • Elysium Health Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

“Anti-Aging Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-aging drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-aging drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The anti-aging drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Serums; Creams; Gels; Other Products
• 2) By Drug Class: Hormonal Therapy; Antioxidants; Enzymes; Stem Cells
• 3) By Type: Injectable; Oral; Topical
• 4) By Ingredient: Retinoid; Hyaluronic Acid; Alpha Hydroxy Acid; Other Ingredients
• 5) By Drug Application: Skin And Hair; Skeletal And Muscles; Age Related Disorders; Other Applications
• Companies Mentioned: L'Oreal S.A.; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Sanofi S.A.; Elysium Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Anti-aging drugs are a category of medications or supplements designed to decelerate or potentially reverse the aging process, addressing the underlying causes of aging and aiming to alleviate age-related illnesses.

The primary types of anti-aging drugs include serums, creams, gels, and other formulations. Serums are clear, yellowish liquids that remain after blood clotting and removal of blood cells. These drugs fall into various classes, including hormonal therapy, antioxidants, enzymes, stem cells, and others, available in forms such as injectables, oral medications, and topical applications. Various ingredients such as retinoid, hyaluronic acid, alpha hydroxy acid, among others, are applied to the skin and hair, targeting skeletal and muscle health, age-related disorders, and other aspects of the aging process.

The anti-aging drugs market research report is one of a series of new reports from The Business Research Company that provides anti-aging drugs market statistics, including anti-aging drugs industry global market size, regional shares, competitors with a anti-aging drugs market share, detailed anti-aging drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-aging drugs industry. This anti-aging drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-aging drugs market size has grown strongly in recent years. It will grow from $53.76 billion in 2023 to $57.85 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the increase in chronic diseases associated with aging, a growing awareness of aging-related health issues, regulatory support for aging research, and a consumer focus on wellness and longevity. These factors collectively contributed to the development and adoption of anti-aging drugs during this period.

The anti-aging drugs market size is expected to see strong growth in the next few years. It will grow to $77.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period can be attributed to several factors, including the adoption of precision medicine approaches, the emergence of senolytic drugs, increased collaboration and partnerships in research, establishment of regulatory pathways for aging therapeutics, and a growing consumer adoption of anti-aging interventions. Noteworthy trends expected in the forecast period include the development of targeted therapies and personalized medicine, the use of senolytic drugs to address cellular senescence, advancements in gene therapy and CRISPR technologies, a focus on mitochondrial health, and the modulation of the microbiome for longevity.

The growth of the anti-aging drugs market is anticipated to be fueled by the increasing aging population. This demographic shift highlights a rising proportion of individuals aged 60 years or older compared to other age cohorts within societies. This shift is a consequence of advancements in healthcare, resulting in extended lifespans, declining fertility rates, and transformations in social and economic structures. Anti-aging medications are aimed at extending the healthy lifespan of individuals who display youthful characteristics. For instance, according to the World Health Organization in October 2022, projections indicate that by 2030, one in every six individuals globally will be over 60 years old, marking an increase from 1 billion to 1.4 billion elderly individuals by 2020. Additionally, as per the Eurostat database, individuals aged 65 and above constituted 21.1% of the population, witnessing a 0.3% rise from the previous year and a 3.1% increase from a decade earlier. Hence, the surge in the aging population significantly propels the growth of the anti-aging drugs market.

The expansion of the anti-aging drugs market is expected to be driven by an increase in people's disposable income. This rise in disposable income typically correlates with economic improvements, leading to elevated wages, salaries, and heightened healthcare expenditures. Disposable income plays a pivotal role in influencing the usage of anti-aging drugs, as individuals with higher income levels often possess better accessibility and affordability for these treatments. This accessibility contributes to increased utilization, aiming to preserve a youthful appearance and tackle age-related concerns. For instance, data from the Bureau of Economic Analysis in August 2023 revealed a $7.3 billion rise (less than 0.1%) in disposable personal income and a $144.6 billion increase (0.8%) in personal consumption expenditures (PCE). Thus, the upsurge in people's disposable income significantly drives the growth of the anti-aging drugs market.

Embracing product innovation stands as a significant trend gaining traction within the anti-aging drugs market. Companies within this sector are actively integrating innovative products to fortify their market presence. For example, in April 2023, SkinCeuticals, a US-based leader in advanced skincare, unveiled the corrective cream A.G.E Interrupter Advanced. This product amplifies collagen matrix integrity, featuring a formulation infused with wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E Interrupter). A.G.E. Interrupter Advanced sets itself apart from standard anti-aging products by addressing all stages of the glycation process, rectifying existing signs of aging, and safeguarding against new and recurring damage induced by A.G.E. formation.

Leading companies in the anti-aging drug market are channeling efforts towards the development of cutting-edge skincare solutions aimed at combatting age-related conditions, promoting longevity, and enhancing overall health and well-being. Advanced skincare solutions for anti-aging encompass a spectrum of innovative products and treatments meticulously designed to target and diminish aging signs. These solutions elevate skin health and appearance through the utilization of state-of-the-art technologies and formulations. For instance, in August 2022, NutriGlow Cosmetics Pvt. Ltd., an India-based beauty product provider, introduced a limited-edition line of anti-aging skincare products on their platform. This range includes items such as NutriGlow Advanced Organics Anti Pigmentation Serum, Anti Pigmentation Night Cream, Age Repair Tightening Serum, Age Repair Tightening Day Cream, Vitamin C Skin Lightening Serum, and Vitamin C Skin Lightening Night Cream. These dermatologically-tested anti-aging products are infused with Vitamin C and Hyaluronic Acid, addressing various skin concerns such as dark spots, fine lines, hyperpigmentation, discoloration, and uneven skin tone for consumers.

In July 2021, AbbVie Inc., a US-based pharmaceutical company specializing in the discovery and delivery of innovative medicines, successfully acquired Allergan plc for a total of $63 billion. This strategic acquisition is anticipated to bolster AbbVie's position as a well-diversified leader in crucial therapeutic categories. Allergan plc, also based in the United States, is a pharmaceutical company engaged in the manufacturing of medical aesthetics drugs and medical devices, which includes products related to anti-aging skincare.

Major companies operating in the anti-aging drugs market report are L'Oreal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estee Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, Daewoong Pharmaceutical Co. Ltd., MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro

North America was the largest region in the anti-aging drugs market in 2023. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the anti-aging drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The anti-aging drugs market consists of sales of dermal fillers, botulinum toxin, anti-wrinkle products, and anti-stretch mark products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Anti-Aging Drugs Market Characteristics

3. Anti-Aging Drugs Market Trends And Strategies

4. Anti-Aging Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Anti-Aging Drugs Market Size and Growth

• 5.1. Global Anti-Aging Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Anti-Aging Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Anti-Aging Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Anti-Aging Drugs Market Segmentation

• 6.1. Global Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Serums
• Creams
• Gels
• Other Products
• 6.2. Global Anti-Aging Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hormonal Therapy
• Antioxidants
• Enzymes
• Stem Cells
• 6.3. Global Anti-Aging Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Injectable
• Oral
• Topical
• 6.4. Global Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retinoid
• Hyaluronic Acid
• Alpha Hydroxy Acid
• Other Ingredients
• 6.5. Global Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Skin And Hair
• Skeletal And Muscles
• Age Related Disorders
• Other Applications

7. Anti-Aging Drugs Market Regional And Country Analysis

• 7.1. Global Anti-Aging Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Anti-Aging Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Anti-Aging Drugs Market

• 8.1. Asia-Pacific Anti-Aging Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Anti-Aging Drugs Market

• 9.1. China Anti-Aging Drugs Market Overview
• 9.2. China Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Anti-Aging Drugs Market

• 10.1. India Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Anti-Aging Drugs Market

• 11.1. Japan Anti-Aging Drugs Market Overview
• 11.2. Japan Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Anti-Aging Drugs Market

• 12.1. Australia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Anti-Aging Drugs Market

• 13.1. Indonesia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Anti-Aging Drugs Market

• 14.1. South Korea Anti-Aging Drugs Market Overview
• 14.2. South Korea Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Anti-Aging Drugs Market

• 15.1. Western Europe Anti-Aging Drugs Market Overview
• 15.2. Western Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Anti-Aging Drugs Market

• 16.1. UK Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Anti-Aging Drugs Market

• 17.1. Germany Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Anti-Aging Drugs Market

• 18.1. France Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Anti-Aging Drugs Market

• 19.1. Italy Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Anti-Aging Drugs Market

• 20.1. Spain Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Anti-Aging Drugs Market

• 21.1. Eastern Europe Anti-Aging Drugs Market Overview
• 21.2. Eastern Europe Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Anti-Aging Drugs Market

• 22.1. Russia Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Anti-Aging Drugs Market

• 23.1. North America Anti-Aging Drugs Market Overview
• 23.2. North America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Anti-Aging Drugs Market

• 24.1. USA Anti-Aging Drugs Market Overview
• 24.2. USA Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Anti-Aging Drugs Market

• 25.1. Canada Anti-Aging Drugs Market Overview
• 25.2. Canada Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Anti-Aging Drugs Market

• 26.1. South America Anti-Aging Drugs Market Overview
• 26.2. South America Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Anti-Aging Drugs Market

• 27.1. Brazil Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Anti-Aging Drugs Market

• 28.1. Middle East Anti-Aging Drugs Market Overview
• 28.2. Middle East Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Anti-Aging Drugs Market

• 29.1. Africa Anti-Aging Drugs Market Overview
• 29.2. Africa Anti-Aging Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Anti-Aging Drugs Market, Segmentation By Ingredient, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Anti-Aging Drugs Market, Segmentation By Drug Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Anti-Aging Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anti-Aging Drugs Market Competitive Landscape
• 30.2. Anti-Aging Drugs Market Company Profiles
  • 30.2.1. L'Oreal S.A.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Galderma S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merz Pharma GmbH & Co. KGaA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Elysium Health Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Anti-Aging Drugs Market Competitive Benchmarking

32. Global Anti-Aging Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Anti-Aging Drugs Market

34. Anti-Aging Drugs Market Future Outlook and Potential Analysis

• 34.1 Anti-Aging Drugs Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Anti-Aging Drugs Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Anti-Aging Drugs Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer